MindTrace fuses neuroimaging with measures of a neurosurgery patient’s behavioural performance, simulates surgical resection plans, and predicts cognitive outcomes – all before the first incision, or in real-time during surgery Image Problem Neurosurgical interventions to remove brain tumours or treat medically refractory epilepsy strive to not cause post-operative cognitive deficits in patients. However, as many as 4 in 5 neurosurgery patients self-report a post-operative deficit that negatively affects their quality of life. Ultimately, patients want confidence they will be the same person coming out of brain surgery as they were going into surgery—and clinical teams want tools that support quantitative pre-operative surgical planning and evidence-based projections of post-operative function. Solution MindTrace is a clinical decision support tool that reduces uncertainty associated with neurosurgery. The platform is software as a medical device (SaMD) that leverages AI/ML to support quantitative pre-operative neurosurgical planning and evidence-based projections of post-operative function. This allows clinical teams to visualize and iterate on their surgical plan by exploring different paths of approach to a lesion, and the consequences of being more or less aggressive with the resections at the margin between lesion and healthy brain tissue. Links Website LinkedIn This article was published on 2024-09-30
